eFFECTOR Therapeutics Inc (EFTR) News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:June 26, 2023...

Current Report Filing (8-k)

false 0001828522 --12-31 0001828522 2023-06-22 2023-06-22 0001828522 eftr:CommonStock0.0001ParValuePerShare2Member 2023-06-22 2023-06-22...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-262339 Prospectus Supplement...

Current Report Filing (8-k)

false 0001828522 0001828522 2023-06-06 2023-06-06 0001828522 eftr:CommonStock0.0001ParValuePerShare2Member 2023-06-06 2023-06-06 0001828522...